VSIR and neoplasm: Notably, VISTA has been identified in varying proportions within tumor cells across a spectrum of cancers, such as NSCLC, hepatocellular carcinoma, ovarian and endometrial cancers, melanoma, gastric cancer, and breast cancer (21).